Esthesioneuroblastoma natural history, complications and prognosis: Difference between revisions
No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Esthesioneuroblastoma}} | {{Esthesioneuroblastoma}} | ||
{{CMG}}{{AE}}{{Simrat}} | |||
==Overview== | |||
==Natural History== | |||
==Complications== | |||
==Prognosis== | |||
Most studies have found a correlation between Hyams grade and prognosis [13,17,21,23]. In a meta-analysis that included five studies in which lesions were graded histologically, the mean five-year survival was 56 percent for those with low-grade lesions (Hyams I and II) versus 20 percent for those with high-grade lesions (Hyams III and IV) [23]. However, a SEER study of 281 patients treated from 1973 to 2010 showed that patients with grade I and II tumors had a 10-year overall survival rate of 67 percent and those with high grade tumors (III and IV) had a 10-year overall survival rate of 34 percent. For high-grade tumors, multivariate analysis showed Kadish stage predicted for worse disease-specific survival and radiation independently predicted for improved disease-specific survival (B-Tajudden). | |||
==References== | ==References== | ||
Revision as of 16:40, 14 January 2016
|
Esthesioneuroblastoma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Esthesioneuroblastoma natural history, complications and prognosis On the Web | |
|
American Roentgen Ray Society Images of Esthesioneuroblastoma natural history, complications and prognosis | |
|
FDA on Esthesioneuroblastoma natural history, complications and prognosis | |
|
CDC on Esthesioneuroblastoma natural history, complications and prognosis | |
|
Esthesioneuroblastoma natural history, complications and prognosis in the news | |
|
Blogs on Esthesioneuroblastoma natural history, complications and prognosis | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Natural History
Complications
Prognosis
Most studies have found a correlation between Hyams grade and prognosis [13,17,21,23]. In a meta-analysis that included five studies in which lesions were graded histologically, the mean five-year survival was 56 percent for those with low-grade lesions (Hyams I and II) versus 20 percent for those with high-grade lesions (Hyams III and IV) [23]. However, a SEER study of 281 patients treated from 1973 to 2010 showed that patients with grade I and II tumors had a 10-year overall survival rate of 67 percent and those with high grade tumors (III and IV) had a 10-year overall survival rate of 34 percent. For high-grade tumors, multivariate analysis showed Kadish stage predicted for worse disease-specific survival and radiation independently predicted for improved disease-specific survival (B-Tajudden).